Skip to main content

The 2022 French Strategy on biotherapies and bioproduction of advanced therapies: results after 3 years launch and perspectives

Presentation on French Strategy at EuroGCT Lunchtime Symposium during the ESGCT Congress, 10 October 2025, Sevilla, Spain. 

The EuroGCT Lunchtime Symposium provides an overview and discusses with policy- and law-makers, and regulators, the policy strategies at stake and their current and prospective impact on the regulation of gene and cell therapy in Europe.

 

presentation:

The 2022 French Strategy on biotherapies and bioproduction of advanced therapies: results after 3 years launch and perspectives

 

Speaker: 

Emmanuel Dequier, Project officer in Health Innovation at the Ministry of Higher Education and Research

 

The 2022 French Strategy on biotherapies and bioproduction of advanced therapies: results after 3 years launch and perspectives

 

Please download and view the PDF file of this presentation from the attachment section below.

Czy uważasz informacje na tej stronie za pomocne? Przyślij nam swoje uwagi
-
Your feedback helps us keep EuroGCT online. Please can you take 30 seconds to answer these quick questions?
How would you rate your experience using EuroGCT.org today?
Poor
Great
Is the information on this website understandable?
Not at all understandable
Very understandable
Is the information on this website useful?
Not at all useful
Very useful
Is the website easy to use and navigate?
Not at all easy
Very easy
Why are you interested in gene and cell therapies and research?
CAPTCHA
To pytanie sprawdza czy jesteś człowiekiem i zapobiega wysyłaniu spamu.